Treatment, Medication & Supplement Directory

A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.

Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Dogs & Cats · After Chemotherapy · During Chemotherapy · Published Study

Lomustine (CCNU) in Veterinary Oncology: Delayed-Toxicity Safety Profile

Lomustine, also called CCNU, is an oral nitrosourea chemotherapy drug used by veterinary oncologists for selected cancers. Use in dogs and cats is generally extra-label and requires a…

Read more

Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Dogs & Cats · After Chemotherapy · Before Chemotherapy · During Chemotherapy

Metronomic Chemotherapy: Goal, Evidence, and Handling Boundary

Metronomic therapy uses regularly scheduled cytotoxic medication in selected plans; it remains prescription hazardous-drug treatment and is not simply gentle chemotherapy.

Read more

Chemotherapy · Dogs & Cats · After Chemotherapy · Before Chemotherapy · During Chemotherapy · Published Study · Veterinary Clinical Use

Home Handling of Oral Chemotherapy and Patient Waste

Families need drug-specific written instructions for receiving, storing, administering, cleaning, laundering, and disposing of chemotherapy and contaminated patient waste.

Read more

Named profile · oral cytotoxic medicationTemozolomide in Veterinary Oncology: Oral Alkylator and Evidence BoundaryRepresentative category illustration – no product packaging is shown.

Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Triazene antineoplastic agents · Dogs & Cats · During Chemotherapy · New Diagnosis

Temozolomide in Veterinary Oncology: Oral Alkylator and Evidence Boundary

temozolomide is covered as triazene antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more

Named profile · oral cytotoxic medicationHydroxyurea in Veterinary Oncology: Myeloproliferative-Disease ProfileRepresentative category illustration – no product packaging is shown.

Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Ribonucleotide-reductase inhibitors · Dogs & Cats · During Chemotherapy · New Diagnosis

Hydroxyurea in Veterinary Oncology: Myeloproliferative-Disease Profile

hydroxyurea is covered as ribonucleotide-reductase inhibitors; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more

Named profile · oral cytotoxic medicationProcarbazine in Veterinary Oncology: MOPP/LOPP Component and Safety ProfileRepresentative category illustration – no product packaging is shown.

Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Methylhydrazine antineoplastic agents · Dogs & Cats · During Chemotherapy · New Diagnosis

Procarbazine in Veterinary Oncology: MOPP/LOPP Component and Safety Profile

procarbazine is covered as methylhydrazine antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more

Named profile · injectable chemotherapyPaclitaxel in Veterinary Oncology: Formulation and Regulatory-History ProfileRepresentative category illustration – no product packaging is shown.

Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Taxane antineoplastic agents · Dogs · During Chemotherapy · New Diagnosis

Paclitaxel in Veterinary Oncology: Formulation and Regulatory-History Profile

paclitaxel is covered as taxane antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more

Named profile · injectable chemotherapyDocetaxel in Veterinary Oncology: Limited-Evidence Taxane ProfileRepresentative category illustration – no product packaging is shown.

Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Taxane antineoplastic agents · Dogs · During Chemotherapy · New Diagnosis

Docetaxel in Veterinary Oncology: Limited-Evidence Taxane Profile

docetaxel is covered as taxane antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more

Named profile · chemotherapy protocolCOP / CVP Lymphoma Chemotherapy: Veterinary Protocol ProfileRepresentative category illustration – no product packaging is shown.

Chemotherapy · Prescription Drug · COP / CVP lymphoma protocols · Dogs & Cats · During Chemotherapy · New Diagnosis · Published Study

COP / CVP Lymphoma Chemotherapy: Veterinary Protocol Profile

cyclophosphamide, vincristine (Oncovin) and prednisone or prednisolone is covered as multi-agent lymphoma chemotherapy protocol, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more

Named profile · chemotherapy protocolMOPP and LOPP for Canine Lymphoma: Distinct Alkylator-Rich ProtocolsRepresentative category illustration – no product packaging is shown.

Chemotherapy · Prescription Drug · MOPP / LOPP lymphoma protocols · Dogs · After Chemotherapy · During Chemotherapy · New Diagnosis

MOPP and LOPP for Canine Lymphoma: Distinct Alkylator-Rich Protocols

MOPP and LOPP multi-agent chemotherapy is covered as alkylator-rich canine lymphoma protocols, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more